| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2016 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PG&E CORP | 20 | Q2 2023 | 0.8% |
| EXACT SCIENCES CORP | 20 | Q3 2023 | 1.1% |
| BED BATH & BEYOND INC | 20 | Q2 2023 | 0.1% |
| AURINIA PHARMACEUTICALS INC | 19 | Q3 2023 | 0.4% |
| SAREPTA THERAPEUTICS INC | 18 | Q3 2023 | 1.2% |
| UNIQURE NV | 18 | Q3 2023 | 2.4% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2023 | 1.0% |
| UNIQURE NV | 18 | Q3 2023 | 1.0% |
| AMICUS THERAPEUTICS INC | 18 | Q3 2023 | 0.2% |
| SUNRUN INC | 17 | Q3 2023 | 2.4% |
View Caption Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| SC 13G | 2022-09-02 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Caption Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.